Virtu Financial’s Haemonetics HAE Stock Holding History

Virtu Financial’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$503K	Buy	+6,711	New	+$431K	0.02%	522
2026 Q1	–	Sell	-5,645	Closed	-$452K	–	1908
2025 Q4	$452K	Buy	+5,645	New	+$379K	0.02%	651
2024 Q1	–	Sell	-5,964	Closed	-$510K	–	1681
2023 Q4	$510K	Buy	+5,964	New	+$516K	0.04%	405
2022 Q1	–	Sell	-9,154	Closed	-$486K	–	1703
2021 Q4	$486K	Buy	+9,154	New	+$558K	0.05%	380
2021 Q2	–	Sell	-4,726	Closed	-$525K	–	1730
2021 Q1	$525K	Buy	+4,726	New	+$585K	0.04%	501
2019 Q4	$1.03M	Buy	+8,932	New	+$1.08M	0.1%	212
2019 Q2	–	Sell	-4,532	Closed	-$396K	–	1615
2019 Q1	$396K	Buy	+4,532	New	+$412K	0.02%	671
2018 Q2	–	Sell	-8,028	Closed	-$587K	–	2186
2018 Q1	$587K	Buy	+8,028	New	+$551K	0.03%	626

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtu Financial's HAE Position: Q2 2026 in Review

Virtu Financial opened a new position in Haemonetics (HAE) in Q2 2026: 6,711 shares worth $503K. The stake represents 0.02% of the portfolio and ranks #522 among its holdings. This is a return to the name: Virtu Financial previously reported a position in HAE as recently as Q4 2025.

Virtu Financial first reported a position in HAE in Q1 2018 and has held it in 8 quarters since. The position peaked at $1.03M in Q4 2019. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

Virtu Financial held 6,711 shares of Haemonetics worth $503K as of Q2 2026.
Haemonetics was a new Virtu Financial position in Q2 2026.
Haemonetics made up 0.02% of Virtu Financial's portfolio in Q2 2026, its #522 holding.
Virtu Financial first reported a position in Haemonetics in Q1 2018 and has held it in 8 quarters since.
Virtu Financial's Haemonetics position peaked at $1.03M in Q4 2019.
329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.